Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
4.070
+0.010 (0.25%)
At close: Nov 22, 2024, 4:00 PM
4.050
-0.020 (-0.49%)
After-hours: Nov 22, 2024, 7:38 PM EST
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 122 employees as of December 31, 2023. The number of employees decreased by 62 or -33.70% compared to the previous year.
Employees
122
Change (1Y)
-62
Growth (1Y)
-33.70%
Revenue / Employee
$1,667
Profits / Employee
-$925,214
Market Cap
106.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
MultiPlan | 2,800 |
FONAR | 561 |
Karyopharm Therapeutics | 325 |
Journey Medical | 41 |
Avalo Therapeutics | 19 |
INmune Bio | 17 |
Monopar Therapeutics | 10 |
Coya Therapeutics | 8 |
INO News
- 7 days ago - European And US Vaccine Stocks Are Under Pressure - Here's WHy - Benzinga
- 8 days ago - Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights - PRNewsWire
- 9 days ago - Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial - PRNewsWire
- 16 days ago - INOVIO to Present at Upcoming Scientific Conferences - PRNewsWire
- 16 days ago - INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024 - PRNewsWire
- 4 weeks ago - INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP - PRNewsWire
- 7 weeks ago - INOVIO Reports Inducement Grants Under Inducement Plan - PRNewsWire